Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells
B2 miceta-roglobulin knockout K562 cell-based artificial antigen presenting cells for ex vivo expansion of T lymphocytes